Enhancing the bioactivity of Poly(lactic-co-glycolic acid) scaffold with a nano-hydroxyapatite coating for the treatment of segmental bone defect in a rabbit model

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 1855-1865

  Wang, De Xin ^a   He, Yao ^b   Bi, Long ^a   Qu, Ze Hua ^b   Zou, Ji Wei ^a   Pan, Zhen ^b   Fan, Jun Jun ^a   Chen, Liang ^b   Dong, Xin ^a   Liu, Xiang Nan ^b   Pei, Guo Xian ^a   Ding, Jian Dong ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

BMSCs; Bone defect; Bone tissue engineering; Nano hydroxyapatite; PLGA

Indexed keywords

HYDROXYAPATITE; NANOHYDROXYAPATITE; NANOMATERIAL; POLYGLACTIN; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; BODY FLUID; BONE DEFECT; BONE MARROW CELL; BONE REGENERATION; BONE REMODELING; BONE TISSUE; CELL PROLIFERATION; CELL TRANSPLANTATION; CELL VIABILITY; CERAMICS; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MATERIAL COATING; NONHUMAN; OSSIFICATION; POROSITY; RABBIT; RADIUS; SIMULATION; STROMA CELL; SURFACE PROPERTY; TISSUE STRUCTURE;

BMSCS; BONE DEFECT; BONE TISSUE ENGINEERING; NANO-HYDROXYAPATITE; PLGA;

ANIMALS; BONE REGENERATION; BONE SUBSTITUTES; CELL ADHESION; DURAPATITE; HISTOCYTOCHEMISTRY; LACTIC ACID; MODELS, BIOLOGICAL; NANOCOMPOSITES; POLYGLYCOLIC ACID; POROSITY; RABBITS; RADIUS; TISSUE SCAFFOLDS; X-RAY MICROTOMOGRAPHY;

EID: 84877718986     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S43706     Document Type: Article

References (44)

1. Bhatt RA, Rozental TD. Bone graft substitutes. Hand clin. 2012;28(4): 457-468.
2. Van der Stok J, Van Lieshout EM, El-Massoudi Y, Van Kralingen GH, Patka P. Bone substitutes in The Netherlands - a systematic literature review. Acta biomater. 2011;7(2):739-750.
3. Zhang ZY, Teoh SH, Chong MS, et al. Neo-vascularization and bone formation mediated by fetal mesenchymal stem cell tissue-engineered bone grafts in critical-size femoral defects. Biomaterials. 2010;31(4): 608-620.
4. Park SH, Park DS, Shin JW, et al. Scaffolds for bone tissue engineering fabricated from two different materials by the rapid prototyping technique: PCL versus PLGA. J Mater Sci Mater Med. 2012;23(11): 2671-2678.
5. Wu LB, Zhang H, Zhang JC, Ding JD. Fabrication of three-dimensional porous scaffolds of complicated shape for tissue engineering. I. Compression molding based on flexible-rigid combined mold. Tissue Eng. 2005;11(7-8):1105-1114.
6. Pan Z, Ding JD. Poly(lactide-co-glycolide) porous scaffolds for tissue engineering and regenerative medicine. Interface focus. 2012; 2(3):366-377.
7. Zhang P, Wu H, Wu H, et al. RGD-conjugated copolymer incorporated into composite of poly(lactide-co-glycotide) and poly(L-lactide)-grafted nanohydroxyapatite for bone tissue engineering. Biomacromolecules. 2011;12(7):2667-2680.
8. Ge S, Zhao N, Wang L, et al. Bone repair by periodontal ligament stem cellseeded nanohydroxyapatite-chitosan scaffold. Int J Nanomedicine. 2012;7:5405-5414.
9. Wang Z, Li M, Yu B, Cao L, Yang Q, Su J. Nanocalcium-deficient hydroxyapatite-poly (e-caprolactone)-polyethylene glycol-poly (e-caprolactone) composite scaffolds. Int J Nanomedicine. 2012;7: 3123-3131.
10. Cao L, Duan PG, Wang HR, et al. Degradation and osteogenic potential of a novel poly(lactic acid)/nano-sized β-tricalcium phosphate scaffold. Int J Nanomedicine. 2012;7:5881-5888.
11. Anselme K. Osteoblast adhesion on biomaterials. Biomaterials. 2000; 21(7):667-681.
12. Liu H, Webster TJ. Nanomedicine for implants: a review of studies and necessary experimental tools. Biomaterials. 2007;28(2):354-369.
13. Santos MI, Unger RE, Sousa RA, Reis RL, Kirkpatrick CJ. Crosstalk between osteoblasts and endothelial cells co-cultured on a polycaprolactone-starch scaffold and the in vitro development of vascularization. Biomaterials. 2009;30(26):4407-4415.
14. Santos MI, Tuzlakoglu K, Fuchs S, et al. Endothelial cell colonization and angiogenic potential of combined nanoand micro-fibrous scaffolds for bone tissue engineering. Biomaterials. 2008;29(32):4306-4313.
15. Wu LB, Ding JD. Effects of porosity and pore size on in vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering. J Biomed Mater Res A. 2005;75A(4):767-777.
16. Wu LB, Zhang JC, Jing DY, Ding JD. "Wet-state" mechanical propertiesof three-dimensional polyester porous scaffolds. J Biomed Mater Res A. 2006;76A(2):264-271.
17. Zhang JC, Wu LB, Jing DY, Ding JD. A comparative study of porous scaffolds with cubic and spherical macropores. Polymer. 2005;46(13): 4979-4985.
18. Wu LB, Ding JD. In vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials. 2004;25(27):5821-5830.
19. Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials. 2006;27(15):2907-2915.
20. Bi L, Hu Y, Fan H, et al. Treatment of contaminated bone defects with clindamycin-reconstituted bone xenograft-composites. J Biomed Mater Res B Appl Biomater. 2007;82(2):418-427.
21. Tu J, Wang H, Li H, Dai K, Wang J, Zhang X. The in vivo bone formation by mesenchymal stem cells in zein scaffolds. Biomaterials. 2009;30(26):4369-4376.
22. Omae H, Mochizuki Y, Yokoya S, Adachi N, Ochi M. Augmentation of tendon attachment to porous ceramics by bone marrow stromal cells in a rabbit model. Int Orthop. 2007;31(3):353-358.
23. Mygind T, Stiehler M, Baatrup A, et al. Mesenchymal stem cell ingrowth and differentiation on coralline hydroxyapatite scaffolds. Biomaterials. 2007;28(6):1036-1047.
24. An YH, Friedman RJ. Animal models of orthopedic implant infection. J Invest Surg. 1998;11(2):139-146.
25. Mokbel N, Bou Serhal C, Matni G, Naaman N. Healing patterns of critical size bony defects in rat following bone graft. Oral Maxillofac Surg. 2008;12(2):73-78.
26. Bodde EW, Spauwen PH, Mikos AG, Jansen JA. Closing capacity of segmental radius defects in rabbits. J Biomed Mater Res A. 2008;85(1): 206-217.
27. Amini AR, Adams DJ, Laurencin CT, Nukavarapu SP. Optimally porous and biomechanically compatible scaffolds for large-area bone regeneration. Tissue Eng Pat A. 2012;18(13-14):1376-1388.
28. Henslee AM, Spicer PP, Yoon DM, et al. Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects. Acta Biomater. 2011;7(10):3627-3637.
29. Wu LB, Jing DY, Ding JD. A "room-temperature" injection molding/ particulate leaching approach for fabrication of biodegradable threedimensional porous scaffolds. Biomaterials. 2006;27(2):185-191.
30. Wang Z, Zhang Z, Zhang JC, She ZJ, Ding JD. Distribution of bone marrow stem cells in large porous polyester scaffolds. Chinese Sci Bull. 2009;54(17):2968-2975.
31. Nicula R, Lüthen F, Stir M, Nebe B, Burkel E. Spark plasma sintering synthesis of porous nanocrystalline titanium alloys for biomedical applications. Biomol Eng. 2007;24(5):564-567.
32. Asti A, Visai L, Dorati R, et al. Improved cell growth by Bio-Oss/PLA scaffolds for use as a bone substitute. Technol Health Care. 2008;16(6): 401-413.
33. Webster TJ, Siegel RW, Bizios R. Osteoblast adhesion on nanophase ceramics. Biomaterials. 1999;20(13):1221-1227.
34. Jiao Y, Liu Z, Zhou C. Fabrication and characterization of PLLA-chitosan hybrid scaffolds with improved cell compatibility. J Biomed Mater Res A. 2007;80(4):820-825.
35. Peng R, Yao X, Ding JD. Effect of cell anisotropy on differentiation of stem cells on micropatterned surfaces through the controlled single cell adhesion. Biomaterials. 2011;32(32):8048-8057.
36. Pan Z, Yan C, Peng R, Zhao YC, He Y, Ding JD. Control of cell nucleus shapes via micropillar patterns. Biomaterials. 2012;33(6):1730-1735.
37. Peng R, Yao X, Cao B, Tang J, Ding JD. The effect of culture conditions on the adipogenic and osteogenic inductions of mesenchymal stem cells on micropatterned surfaces. Biomaterials. 2012;33(26):6008-6019.
38. Yao X, Peng R, Ding JD. Effects of aspect ratios of stem cells on lineage commitments with and without induction media. Biomaterials. 2013; 34(4):930-939.
39. Wang X, Yan C, Ye K, He Y, Li ZH, Ding JD. Effect of RGD nanospacing on differentiation of stem cells. Biomaterials. 2013;34(12):2865-2874.
40. Busa WB, Nuccitelli R. Metabolic regulation via intracellular pH. Am J Physiol. 1984;246(4 Pt 2):R409-R438.
41. Huang J, Best SM, Bonfield W, et al. In vitro assessment of the biological response to nano-sized hydroxyapatite. J Mater Sci Mater Med. 2004;15(4):441-445.
42. Pezzatini S, Solito R, Morbidelli L, et al. The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions. J Biomed Mater Res A. 2006;76(3):656-663.
43. Bernards MT, Qin C, Jiang S. MC3T3-E1 cell adhesion to hydroxyapatite with adsorbed bone sialoprotein, bone osteopontin, and bovine serum albumin. Colloids Surf B Biointerfaces. 2008;64(2):236-247.
44. Lewandrowski KU, Bondre SP, Wise DL, Trantolo DJ. Enhanced bioactivity of a poly(propylene fumarate) bone graft substitute by augmentation with nano-hydroxyapatite. Biomed Mater Eng. 2003;13(2): 115-124.